Disease Markers / 2013 / Article / Fig 2

Research Article

Comparison of the Diagnostic Accuracy of the MSLN Gene Products, Mesothelin and Megakaryocyte Potentiating Factor, as Biomarkers for Mesothelioma in Pleural Effusions and Serum

Figure 2

Biomarker concentrations in serum: biomarker concentrations were determined at least in duplicate by ELISA and individual patient values plotted. (a) MPF as determined using N-ERC assay from IBL; (b) MPF as determined using assay from MBL; (c) correlation between MPF concentrations determined by the two different independent assays; (d) correlation between MPF concentrations determined by MBL assays and mesothelin; (e) soluble mesothelin concentrations; and (f) Receiver Operating Characteristic (ROC) curves showing accuracy of serum biomarkers in differentiating all patients with MM ( ) from all other cases ( ). (Significant difference between indicated cohorts: ns is not significant; *** .)
874212.fig.002a
(a)
874212.fig.002b
(b)
874212.fig.002c
(c)
874212.fig.002d
(d)
874212.fig.002e
(e)
874212.fig.002f
(f)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.